《日本循环学会（JCS）2020年冠状动脉疾病患者抗栓治疗指南重点更新》 - Suppr

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.

作者信息

Nakamura Masato, Kimura Kazuo, Kimura Takeshi, Ishihara Masaharu, Otsuka Fumiyuki, Kozuma Ken, Kosuge Masami, Shinke Toshiro, Nakagawa Yoshihisa, Natsuaki Masahiro, Yasuda Satoshi, Akasaka Takashi, Kohsaka Shun, Haze Kazuo, Hirayama Atsushi

机构信息

Division of Cardiovascular Medicine, Toho University Ohashi Medical Center.

Division of Cardiology, Yokohama City University Medical Center.

出版信息

Circ J. 2020 Apr 24;84(5):831-865. doi: 10.1253/circj.CJ-19-1109. Epub 2020 Mar 13.

DOI:10.1253/circj.CJ-19-1109

PMID:32173684

Abstract

摘要

相似文献

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.《日本循环学会（JCS）2020年冠状动脉疾病患者抗栓治疗指南重点更新》

Circ J. 2020 Apr 24;84(5):831-865. doi: 10.1253/circj.CJ-19-1109. Epub 2020 Mar 13.

Will We Ever Decide What Antithrombotic Regimen to Use After Stenting?我们究竟何时才能确定支架置入术后使用何种抗血栓治疗方案？

Cardiovasc Revasc Med. 2020 May;21(5):702-703. doi: 10.1016/j.carrev.2020.05.026.

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗血栓治疗：北美视角-2018 年更新。

Circulation. 2018 Jul 31;138(5):527-536. doi: 10.1161/CIRCULATIONAHA.118.034722.

A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.多学科方法在冠状动脉支架置入术后手术患者围手术期抗栓治疗中的应用：支架术后手术 2 。

JACC Cardiovasc Interv. 2018 Mar 12;11(5):417-434. doi: 10.1016/j.jcin.2017.10.051.

Controversies in the Cath Lab: Navigating Contemporary Conundrums Before, During and After Intervention.心脏导管室的争议：应对介入治疗前、中、后的当代难题

Curr Vasc Pharmacol. 2018;16(5):416-417. doi: 10.2174/1570161116666180117144355.

Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.双联或三联抗栓治疗患者的出血和缺血结局：系统评价和荟萃分析。

Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):226-236. doi: 10.1093/ehjcvp/pvz021.

Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.心房颤动和冠心病患者经皮冠状动脉介入治疗中的抗血栓治疗。

J Cardiovasc Pharmacol. 2019 Aug;74(2):82-90. doi: 10.1097/FJC.0000000000000697.

Antithrombotic Treatment Regimens in Patients Undergoing Percutaneous Coronary Revascularization Requiring Oral Anticoagulation: What Real-World Evidence Shows Us.接受经皮冠状动脉血运重建且需要口服抗凝治疗的患者的抗栓治疗方案：真实世界证据向我们展示了什么。

J Cardiovasc Pharmacol. 2024 Oct 1;84(4):391-393. doi: 10.1097/FJC.0000000000001619.

SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease.SCAI关于复杂冠状动脉疾病最佳经皮冠状动脉介入治疗的立场声明。

Catheter Cardiovasc Interv. 2020 Aug;96(2):346-362. doi: 10.1002/ccd.28994. Epub 2020 Jun 4.

Stent Thrombosis in Patients With Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.AUGUSTUS试验中接受冠状动脉支架置入术的房颤患者的支架内血栓形成

Circulation. 2020 Mar 3;141(9):781-783. doi: 10.1161/CIRCULATIONAHA.119.044584. Epub 2019 Nov 11.

引用本文的文献

Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial.利伐沙班单药治疗稳定型冠状动脉疾病合并心房颤动的年龄分层效应：AFIRE随机临床试验的事后分析

JAMA Cardiol. 2025 Aug 13. doi: 10.1001/jamacardio.2025.2611.

Decoding Bleeding Risks and Survival in Patients Undergoing Percutaneous Coronary Intervention on Antiplatelet Therapy.解读接受抗血小板治疗的经皮冠状动脉介入治疗患者的出血风险和生存率

JACC Asia. 2025 Sep;5(9):1083-1094. doi: 10.1016/j.jacasi.2025.05.017. Epub 2025 Jul 29.

Predictors of failure in the reverse wire technique for complex coronary bifurcation lesions.复杂冠状动脉分叉病变反向导丝技术失败的预测因素

AsiaIntervention. 2025 Jul 30;11(2):e110-e118. doi: 10.4244/AIJ-D-24-00069. eCollection 2025 Jul.

Long-Term Outcomes Following Percutaneous Coronary Intervention With Rotational Atherectomy for Severely Calcified Lesions.严重钙化病变经皮冠状动脉介入旋磨术的长期预后

Circ Rep. 2025 Jun 17;7(7):528-534. doi: 10.1253/circrep.CR-25-0061. eCollection 2025 Jul 10.

Position Statement on Antiplatelet Therapy for East Asians With Coronary Artery Disease: 2025 Update.《2025年东亚冠状动脉疾病患者抗血小板治疗立场声明更新版》

JACC Asia. 2025 Jul;5(7):821-846. doi: 10.1016/j.jacasi.2025.04.010.

An Aspirin-Free Strategy for Patients Undergoing Staged Percutaneous Coronary Intervention　- A Subgroup Analysis of the STOPDAPT-3 Trial.接受分期经皮冠状动脉介入治疗患者的无阿司匹林策略——STOPDAPT-3试验的亚组分析

Circ Rep. 2025 Apr 29;7(6):451-462. doi: 10.1253/circrep.CR-25-0026. eCollection 2025 Jun 10.

Long-term bleeding events post-percutaneous coronary intervention in patients with malignancy with and without anticoagulant therapy.接受或未接受抗凝治疗的恶性肿瘤患者经皮冠状动脉介入治疗后的长期出血事件

Cardiovasc Interv Ther. 2025 Jun 9. doi: 10.1007/s12928-025-01151-4.

Dual antiplatelet therapy in GI-bleed patients with extensive coronary artery disease history: a systematic review.有广泛冠状动脉疾病史的胃肠道出血患者的双重抗血小板治疗：一项系统评价

Ann Med Surg (Lond). 2025 Apr 25;87(6):3715-3735. doi: 10.1097/MS9.0000000000002833. eCollection 2025 Jun.

Antithrombotic Therapy for Acute Coronary Syndrome.急性冠状动脉综合征的抗栓治疗

J Neuroendovasc Ther. 2025;19(1). doi: 10.5797/jnet.ra.2024-0102. Epub 2025 May 27.

Post-discharge major bleeding/all-cause death in acute coronary syndrome: academic research consortium criteria versus Japan-specific criteria.急性冠状动脉综合征出院后大出血/全因死亡：学术研究联盟标准与日本特定标准对比

BMC Cardiovasc Disord. 2025 May 15;25(1):370. doi: 10.1186/s12872-025-04834-1.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

JCS 2020 Guideline Focused Update on Antithrombotic Therapy in Patients With Coronary Artery Disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献